COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

14.11 +0.73 (+5.46%)

Streaming Delayed Price Updated: 2:41 PM EDT, Aug 12, 2026 Add to My Watchlist

Price and Volume

Volume	3,159,821
Open	13.75
Bid (Size)	14.10 (1,000)
Ask (Size)	14.11 (500)
Prev. Close	13.38
Today's Range	13.65 - 14.59
52wk Range	3.970 - 15.40
Shares Outstanding	41,695,335
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript ↗

Today 13:43 EDT

COMP360 shows 39% response rate; commercial launch targeted for H1 2027.

Via The Motley Fool

Compass Pathways Targets 2027 COMP360 Launch as FDA Filing Advances ↗

Today 12:04 EDT

Compass Pathways (NASDAQ:CMPS) said it remains on track to complete a new drug application for COMP360, its investigational psilocybin treatment for treatment-resistant depression, in the fourth...

Via MarketBeat

Performance

YTD	+115.4%	+115.4%
1 Month	+7.0%	+7.0%
3 Month	+50.6%	+50.6%
6 Month	+124.3%	+124.3%
1 Year	+225.1%	+225.1%

More News

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026

August 06, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways (NASDAQ:CMPS) Shares Plunge 42% After Q2 Report Despite Narrower-Than-Expected Loss ↗

August 05, 2026

Via Chartmill

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

August 06, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 05, 2026

From Compass Pathfinder Limited

Via Business Wire

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

August 05, 2026

From USA News Group

Via GlobeNewswire

Compass Pathways Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

August 05, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

July 29, 2026

From Compass Pathfinder Limited

Via Business Wire

Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗

July 29, 2026

Via The Motley Fool

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗

July 23, 2026

Via The Motley Fool

Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates

July 21, 2026

Via FinancialNewsMedia

Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy

July 16, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Eyes 2027 Launch as Psilocybin Depression Data Holds Up ↗

July 10, 2026

Via MarketBeat

Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

July 07, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 02, 2026

From Compass Pathfinder Limited

Via Business Wire

Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

June 30, 2026

Via FinancialNewsMedia

Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

June 30, 2026

From MarketNewsUpdates.com

Via GlobeNewswire

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 05, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Elects Kathleen Tregoning to Board of Directors

May 28, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026

May 26, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins ↗

May 21, 2026

Via MarketBeat

Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026

May 14, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass (CMPS) Q1 2026 Earnings Transcript ↗

May 13, 2026

Via The Motley Fool

Frequently Asked Questions

Is COMPASS Pathways Plc - American Depository Shares publicly traded?

Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.

What exchange does COMPASS Pathways Plc - American Depository Shares trade on?

COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market

What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?

The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market

What is the current price of COMPASS Pathways Plc - American Depository Shares?

The current price of COMPASS Pathways Plc - American Depository Shares is 14.11

When was COMPASS Pathways Plc - American Depository Shares last traded?

The last trade of COMPASS Pathways Plc - American Depository Shares was at 08/12/26 02:41 PM ET

What is the market capitalization of COMPASS Pathways Plc - American Depository Shares?

The market capitalization of COMPASS Pathways Plc - American Depository Shares is 588.32M

How many shares of COMPASS Pathways Plc - American Depository Shares are outstanding?

COMPASS Pathways Plc - American Depository Shares has 588M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.